Skip to main content
. 2022 Sep 26;14:17588359221110162. doi: 10.1177/17588359221110162

Figure 3.

Figure 3.

Algorithm depicting the role of ctDNA for the assessment of PIK3CA mutations in BC patients.

BC, breast cancer; ctDNA, circulating tumor DNA; PIK3CA, phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha.